165 related articles for article (PubMed ID: 34806168)
1. Disparities and trends in the participation of minorities, women, and the elderly in breast, colorectal, lung, and prostate cancer clinical trials.
Javier-DesLoges J; Nelson TJ; Murphy JD; McKay RR; Pan E; Parsons JK; Kane CJ; Kader AK; Derweesh IH; Nodora J; Patel SP; Martinez ME; Rose BS
Cancer; 2022 Feb; 128(4):770-777. PubMed ID: 34806168
[TBL] [Abstract][Full Text] [Related]
2. Participation in cancer clinical trials: race-, sex-, and age-based disparities.
Murthy VH; Krumholz HM; Gross CP
JAMA; 2004 Jun; 291(22):2720-6. PubMed ID: 15187053
[TBL] [Abstract][Full Text] [Related]
3. An evaluation of trends in the representation of patients by age, sex, and diverse race/ethnic groups in bladder and kidney cancer clinical trials.
Javier-DesLoges J; Nelson TJ; Murphy JD; McKay RR; Stewart TF; Kader AK; Derweesh I; Martinez ME; Rose BS
Urol Oncol; 2022 May; 40(5):199.e15-199.e21. PubMed ID: 35431133
[TBL] [Abstract][Full Text] [Related]
4. An examination of the influence of patient race and ethnicity on expressed interest in learning about cancer clinical trials.
Markman M; Petersen J; Montgomery R
J Cancer Res Clin Oncol; 2008 Jan; 134(1):115-8. PubMed ID: 17598129
[TBL] [Abstract][Full Text] [Related]
5. Participation in surgical oncology clinical trials: gender-, race/ethnicity-, and age-based disparities.
Stewart JH; Bertoni AG; Staten JL; Levine EA; Gross CP
Ann Surg Oncol; 2007 Dec; 14(12):3328-34. PubMed ID: 17682824
[TBL] [Abstract][Full Text] [Related]
6. Participation of the elderly, women, and minorities in pivotal trials supporting 2011-2013 U.S. Food and Drug Administration approvals.
Downing NS; Shah ND; Neiman JH; Aminawung JA; Krumholz HM; Ross JS
Trials; 2016 Apr; 17():199. PubMed ID: 27079511
[TBL] [Abstract][Full Text] [Related]
7. Trends in participant race and sex reporting in lung cancer phase III clinical trials.
Aslam FN; Manochakian R; Lou Y; Colon-Otero G; Sher T
Cancer Rep (Hoboken); 2023 Sep; 6 Suppl 1(Suppl 1):e1856. PubMed ID: 37421166
[TBL] [Abstract][Full Text] [Related]
8. Diversity of Participation in Clinical Trials and Influencing Factors: Findings from the Health Information National Trends Survey 2020.
Walker DM; Swoboda CM; Shiu-Yee K; Tarver WL; Nolan TS; Joseph JJ
J Gen Intern Med; 2023 Mar; 38(4):961-969. PubMed ID: 36138277
[TBL] [Abstract][Full Text] [Related]
9. Enrollment Trends and Disparity Among Patients With Lung Cancer in National Clinical Trials, 1990 to 2012.
Pang HH; Wang X; Stinchcombe TE; Wong ML; Cheng P; Ganti AK; Sargent DJ; Zhang Y; Hu C; Mandrekar SJ; Redman MW; Manola JB; Schilsky RL; Cohen HJ; Bradley JD; Adjei AA; Gandara D; Ramalingam SS; Vokes EE
J Clin Oncol; 2016 Nov; 34(33):3992-3999. PubMed ID: 27646951
[TBL] [Abstract][Full Text] [Related]
10. Racial and Ethnic Disparities Among Participants in Precision Oncology Clinical Studies.
Aldrighetti CM; Niemierko A; Van Allen E; Willers H; Kamran SC
JAMA Netw Open; 2021 Nov; 4(11):e2133205. PubMed ID: 34748007
[TBL] [Abstract][Full Text] [Related]
11. Disparities in Representation of Women, Older Adults, and Racial/Ethnic Minorities in Immune Checkpoint Inhibitor Trials.
Riaz IB; Islam M; Khan AM; Naqvi SAA; Siddiqi R; Khakwani KZR; Asghar N; Ikram W; Hussain SA; Singh P; Warner JL; Sonpavde GP; Odedina FT; Kehl KL; Duma N; Bryce AH
Am J Med; 2022 Aug; 135(8):984-992.e6. PubMed ID: 35483426
[TBL] [Abstract][Full Text] [Related]
12. Disparity in Clinical Trial Participation Among Patients with Gastrointestinal Cancer.
Abbas A; Diaz A; Obeng-Gyasi S; Cloyd JM; Ejaz A; Stewart JH; Pawlik TM
J Am Coll Surg; 2022 Apr; 234(4):589-598. PubMed ID: 35290279
[TBL] [Abstract][Full Text] [Related]
13. Racial and Ethnic Differences in Rural-Urban Trends in 5-Year Survival of Patients With Lung, Prostate, Breast, and Colorectal Cancers: 1975-2011 Surveillance, Epidemiology, and End Results (SEER).
Lewis-Thames MW; Langston ME; Khan S; Han Y; Fuzzell L; Xu S; Moore JX
JAMA Netw Open; 2022 May; 5(5):e2212246. PubMed ID: 35587350
[TBL] [Abstract][Full Text] [Related]
14. What factors influence minority use of National Cancer Institute-designated cancer centers?
Huang LC; Ma Y; Ngo JV; Rhoads KF
Cancer; 2014 Feb; 120(3):399-407. PubMed ID: 24452674
[TBL] [Abstract][Full Text] [Related]
15. Racial and Ethnic Disparities in Primary Open-Angle Glaucoma Clinical Trials: A Systematic Review and Meta-analysis.
Allison K; Patel DG; Greene L
JAMA Netw Open; 2021 May; 4(5):e218348. PubMed ID: 34003274
[TBL] [Abstract][Full Text] [Related]
16. Ten-Year Trends in Enrollment of Women and Minorities in Pivotal Trials Supporting Recent US Food and Drug Administration Approval of Novel Cardiometabolic Drugs.
Khan MS; Shahid I; Siddiqi TJ; Khan SU; Warraich HJ; Greene SJ; Butler J; Michos ED
J Am Heart Assoc; 2020 Jun; 9(11):e015594. PubMed ID: 32427023
[TBL] [Abstract][Full Text] [Related]
17. Patient and tumour characteristics associated with inclusion in Cancer patient pathways in Norway in 2015-2016.
Nilssen Y; Brustugun OT; Eriksen MT; Haug ES; Naume B; Møller B
BMC Cancer; 2020 May; 20(1):488. PubMed ID: 32473650
[TBL] [Abstract][Full Text] [Related]
18. Do Current Lung Cancer Clinical Trials Represent All Patient Populations Including Minorities?
Nemala A; Ullah A; Yacur M; Karim NA
Clin Lung Cancer; 2023 Nov; 24(7):573-580. PubMed ID: 37574437
[TBL] [Abstract][Full Text] [Related]
19. Effect of Medicaid Expansion on Receipt of Definitive Treatment and Time to Treatment Initiation by Racial and Ethnic Minorities and at Minority-Serving Hospitals: A Patient-Level and Facility-Level Analysis of Breast, Colon, Lung, and Prostate Cancer.
Nguyen DD; Paciotti M; Marchese M; Cole AP; Cone EB; Kibel AS; Ortega G; Lipsitz SR; Weissman JS; Trinh QD
JCO Oncol Pract; 2021 May; 17(5):e654-e665. PubMed ID: 33974827
[TBL] [Abstract][Full Text] [Related]
20. Representation of older patients in cancer treatment trials.
Trimble EL; Carter CL; Cain D; Freidlin B; Ungerleider RS; Friedman MA
Cancer; 1994 Oct; 74(7 Suppl):2208-14. PubMed ID: 8087794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
